.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Daiichi Sankyo
Healthtrust
Johnson and Johnson
Medtronic
Merck
Julphar
McKinsey
Covington
Cerilliant

Generated: July 25, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas
Abstract:Novel ergoline derivatives formed by reaction of an 8-carboxy ergoline with a carbodiimide and having hypotensive and antiprolatinic activity.
Inventor(s): Salvati; Patricia (Milan, IT), Caravaggi; Anna M. (Milan, IT), Temperilli; Aldemio (Milan, IT), Bosisio; Germano (Milan, IT), Sapini; Osvaldo (Gallarate, IT), di Salle; Enrico (Milan, IT)
Assignee: Farmitalia Carlo Erba, S.p.A. (Milan, IT)
Application Number:06/448,364
Patent Claims: 1. Compounds of formula ##STR3## wherein R.sub.1 is a hydrogen atom or a methyl group; R.sub.2 is a hydrogen atom; R.sub.3 is a hydrogen atom or a methoxy group; R.sub.4 is an alkyl or an alkenyl group selected from methyl, allyl and propyl groups; and each of R.sub.5 and R.sub.6 independently is an alkyl group having from 1 to 3 carbon atoms or a group of the formula (CH.sub.2).sub.n N(CH.sub.3).sub.2 in which n is 3 with the proviso that at least one of R.sub.5 and R.sub.6 is said dimethylaminoalkyl group, and pharmaceutically acceptable addition salts with organic or inorganic acid thereof.

2. A compound according to claim 1 which is selected from the group consisting of:

1-ethyl-3-(3'-dimethylaminopropyl)-3(6'-methylergoline-8'.beta.-carbonyl)-u rea;

1-ethyl-3-(3'-dimethylaminopropyl)-3-(10'.alpha.-methoxy-6'-methylergoline- 8'.beta.-carbonyl)-urea;

1-(3'-dimethylaminopropyl)-3-ethyl-3-(6'-allylergoline-8'.beta.-carbonyl)-u rea; and

1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-n-propylergoline-8'.beta.-carbonyl )-urea.

3. A pharmaceutical composition containing a therapeutically effective amount of a compound according to claim 1, in admixture with a pharmaceutically acceptable carrier for oral or parenteral administration.

4. 1-ethyl-3-(3'dimethylaminopropyl)-3-(6'-allylergoline-8'.beta.-carbonyl) -urea.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
Argus Health
Harvard Business School
McKinsey
Cipla
QuintilesIMS
Express Scripts
Cerilliant
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot